The Oncofertility Consortium® is a national, interdisciplinary initiative designed to explore the reproductive future of cancer survivors. Initial funding was provided by the National Institutes of Health through the NIH Roadmap for Medical Research/Common Fund.
Survival rates among young cancer patients have steadily increased over the past four decades in part because of the development of more effective cancer treatments. Today, both women and men can look forward to life after cancer, yet many may face the possibility of infertility as a result of the disease itself or these lifesaving treatments.
We developed the Oncofertility Consortium® to address the complex health care and quality-of-life issues that concern young cancer patients whose fertility may be threatened by their disease or its treatment.
The Consortium was launched with a grant from the National Institutes of Health and represents a nationwide, interdisciplinary, and interprofessional network of medical specialists, scientists, and scholars who are exploring the relationships between health, disease, survivorship and fertility preservation in young cancer patients. Their work and its findings may also extend to patients who have been diagnosed with other serious diseases and who must undergo fertility-threatening treatments.